Skip to main content

Regulatory clarity urged for CME’s single-stock futures

SEC short selling and market access rules may hamper clearing and broker participation

CME with two directions arrows overlaid

The regulatory treatment of CME’s single-stock futures (SSFs) may require clarification for the contracts to gain wider traction, as a dual-oversight framework introduces securities-based market access and short-selling rules that do not easily fit the futures construct.

CME launched more than 70 SSFs in July, on names including Apple, Nvidia and SpaceX, reviving the product after a six-year hiatus

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Want to know what’s included in our free membership? Click here

Show password
Hide password

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here